Search

everythinglearnresearchcommunity

for

Search:↓

Men with baldness have higher levels of specific proteins, suggesting local hormone production may play a role in hair loss.

The androgen receptor is a promising target for breast cancer treatment, especially in triple-negative cases, but more research is needed for personalized therapies.

The enzymes 5α-reductase and 3α/β-hydroxysteroid oxidoreductase help create brain-active substances from progesterone and testosterone, which could be used for treatment, but more research is needed to ensure their safety and effectiveness.

Minoxidil, finasteride, and hair transplantation combined give best results for hair loss.

ERβ has potential in treating prostate cancer and neurodegenerative diseases, but human studies are needed before clinical use.

PRP treatment may promote hair growth and improve hair density in women with AGA, but more research is needed.

DHT affects testicular development and regulates spermatogenesis in some fish.

The lecture concluded that drugs for human enhancement are here to stay and called for their responsible development and fair access.

The document concludes that sex hormones are crucial for mammalian reproduction, health, and behavior, and require more research for therapeutic use.

Certain genetic variants are linked to frontal fibrosing alopecia in Spanish patients.

Neuroactive steroids may affect the risk and treatment of alcohol use disorders.

The conference presented findings on how vitamin D levels, genetic factors, and lifestyle choices like smoking and yoga affect various health conditions and diseases.

hUC-MSC secretome can help regrow hair in cases of hair loss.

A new method improves platelet testing for heart disease patients.

Vitamins A, B7, C, D, and E are essential for healthy hair growth and preventing damage.

Low-dose glucocorticoid treatment improves pregnancy and birth rates in women with nonclassical 21-hydroxylase deficiency.

Wild African goats have genetic adaptations for surviving harsh desert conditions.

Antiandrogens and androgen inhibitors like spironolactone, finasteride, and dutasteride can treat hair loss and skin conditions, but they have risks and side effects, including potential harm to pregnant women and risks of cancer and heart issues. Herbal remedies also have antiandrogenic effects but lack safety validation.

Leflunomide is effective for rheumatoid arthritis but has significant side effects.

The document concludes that patient outcomes for Congenital Adrenal Hyperplasia are often not ideal because of poor management and a need for better diagnosis and treatment methods.

The method reliably profiles eicosanoids and shows epitestosterone reduces their levels, similar to common anti-inflammatory drugs.

Gene mutations can cause problems in male genital development.

Antiepileptic drugs can cause cosmetic side effects and affect menstrual cycles, fertility, and bone health in women with epilepsy.

Minoxidil, finasteride, and hair transplantation combined give best results for hair loss.

Finasteride and dutasteride reduce neurosteroid production, possibly helping treat glioblastoma.

Treatment with plasma rich in growth factors improved hair density and thickness for hair loss patients.

Men are more likely to get infectious skin diseases, while women are more prone to autoimmune and pigment-related skin conditions, influenced by biological and environmental factors.

Ketoconazole reduced hair growth and improved acne in women, but caused side effects needing careful monitoring.

Arachidonic acid helps hair grow by increasing growth factors and improving follicle health.

Many treatments for hair loss lack proper testing and FDA approval, so their effectiveness is uncertain.